It’s been six years since the US Food and Drug Administration issued draft guidances on the use of social media to provide information about prescription drugs, and stakeholders are eager to know when the agency will be providing further advice.
FDA’s Grail Sipes, deputy center director of the Center for Drug Evaluation and Research, told the Food and Drug Law Institute’s virtual conference on advertising and promotion last week that...